Table 1.
Name, chromosomal location, number of exons, and LU domains for human Ly6/uPAR family genes
| Approved gene symbol (NCBI accession #) | Gene name | Alias(es) | Genomic location | Number of | |
|---|---|---|---|---|---|
| Exons | LU Domains | ||||
|
ACRV1
(NP_001603.1) |
Acrosomal vesicle protein 1 | SP-10; SPACA2; D11S4365 | 11q24.2 | 5 | 1 |
|
CD177
(BAE93254.1) |
CD177 molecule (Human Neutrophil Alloantigen 2A) | NB1; PRV1; HNA2A; PRV-1; HNA-2a; NB1 GP | 19q13.2 | 9 | 2 |
|
CD59
(CAG46523.1) |
CD59 molecule, complement regulatory protein | 1 F5; EJ16; EJ30; EL32; G344; MIN1; MIN2; MIN3; MIRL; HRF20; MACIF; MEM43; MIC11; MSK21; 16.3A5; HRF-20; MAC-IP; p18-20 | 11p13 | 5 | 1 |
|
GML
(EAW82296.1) |
Glycosylphosphatidylinositol anchored molecule like | LY6DL | 8q24.3 | 5 | 1 |
|
GPIHBP1
(AAH35810.2) |
Glycosylphosphatidylinositol anchored high density lipoprotein-binding protein 1 | HYPL1D; GPI-HBP1 | 8q24.3 | 4 | 1 |
|
LY6D
(AAH31330.1) |
Lymphocyte antigen 6 complex, locus D | E48; Ly-6D | 8q24 | 3 | 1 |
|
LY6E
(AAH03392.1) |
Lymphocyte antigen 6 complex, locus E | RIGE; SCA2; RIG-E; SCA-2; TSA-1 | 8q24.3 | 4 | 1 |
|
LY6G5B
(CAC85543.1) |
Lymphocyte antigen 6 complex, locus G5B | G5b; C6orf19 | 6p21.3 | 3 | 1 |
|
LY6G5C
(CAC85542.1) |
Lymphocyte antigen 6 complex, locus G5C | G5C; NG33; C6orf20; LY6G5CA; LY6G5CB | 6p21 | 3 | 1 |
|
LY6G6C
(EAX03491.1) |
Lymphocyte antigen 6 complex, locus G6C | G6c; NG24; C6orf24 | 6p21 | 3 | 1 |
|
LY6G6D
(CAC85540.1) |
Lymphocyte antigen 6 complex, locus G6D | G6D; NG25; LY6-D; MEGT1; C6orf23 | 6p21.3 | 3 | 1 |
|
LY6G6F
(AAI37213.1) |
Lymphocyte antigen 6 complex, locus G6F | G6f; NG32; LY6G6D; C6orf21 | 6p21.33 | 6 | 1 |
|
LY6H
(BAA34115.1) |
Lymphocyte antigen 6 complex, locus H | NMLY6 | 8q24.3 | 4 | 1 |
|
LY6K
(AAI17145.1) |
Lymphocyte antigen 6 complex, locus K | CT97; ly-6 K; URLC10; HSJ001348 | 8q24.3 | 3 | 1 |
|
LY6L
a
(XP_011544859.1) |
Lymphocyte antigen 6 complex, locus L | LOC101928108 | 8q24.3 | 5 | 1 |
|
LYNX1
(NP_803429.1) |
Ly6/neurotoxin 1 | 8q24.3 | 4 | 1 | |
|
LYPD1
(EAX11675.1) |
Ly6/PLAUR domain containing 1 | PHTS; LYPDC1; LYNX2 | 2q21.2 | 3 | 1 |
|
LYPD2
(EAW82307.1) |
Ly6/PLAUR domain containing 2 | LYPDC2; UNQ430 | 8q24.3 | 3 | 1 |
|
LYPD3
(EAW57190.1) |
Ly6/PLAUR domain containing 3 | C4.4A | 19q13.31 | 5 | 2 |
|
LYPD4
(AAH34629.1) |
Ly6/PLAUR domain containing 4 | Sperm Membrane Receptor | 19q13.2 | 5 | 1 |
|
LYPD5
(EAW57232.1) |
Ly6/PLAUR domain containing 5 | PRO4356 | 19q13.31 | 5 | 1 |
|
LYPD6
(AAH47013.1) |
Ly6/PLAUR domain containing 6 | 2q23.2 | 5 | 1 | |
|
LYPD6B
(AAH18203.1) |
Ly6/PLAUR domain containing 6B | CT116; LYPD7 | 2q23.2 | 7 | 1 |
|
LYPD8
(NP_001278212.1) |
Ly6/PLAUR domain containing 8 | 1q44 | 7 | 1 | |
|
PATE1
(AAI07045.1) |
Prostate and testis expressed 1 | PATE | 11q24.2 | 5 | 1 |
|
PATE2
(AAI44527.1) |
Prostate and testis expressed 2 | PATE-M; UNQ3112; C11orf38 | 11q24.2 | 6 | 1 |
|
PATE3
(NP_001123355.3) |
Prostate and testis expressed 3 | HEL-127; PATE-DJ | 11q24.2 | 3 | 1 |
|
PATE4
(NP_001138346.1) |
Prostate and testis expressed 4 | PATE-B | 11q24.2 | 3 | 1 |
|
PINLYP
(NP_001180550.1) |
Phospholipase A2 inhibitor and Ly6/PLAUR domain containing | 19q13.31 | 6 | 1 | |
|
PLAUR
(CAG33233.1) |
Plasminogen activator, urokinase receptor | CD87; UPAR; URKR; U-PAR | 19q13 | 7 | 3 |
|
PSCA
(AAH65183.1) |
Prostate stem cell antigen | PRO232 | 8q24.2 | 3 | 1 |
|
SLURP1
(AAT01436.1) |
Secreted Ly6/PLAUR domain containing 1 | ARS; MDM; ANUP; ArsB; LY6LS | 8q24.3 | 3 | 1 |
|
SLURP2
(NP_803253.1) |
Secreted Ly6/PLAUR domain containing 2 | LYNX1, isoform B precursor | 8q24.3 | 4 | 1 |
|
SPACA4
(AAQ88753.1) |
Sperm acrosome associated 4 | SAMP14 | 19q13.33 | 1 | 1 |
|
TEX101
(EAW57189.1) |
Testis expressed 101 | SGRG; CT131; GTPR867; NYD-SP8; PRO1884; SPATA44; TES101RP | 19q13.31 | 9 | 1 |
aNovel gene named in this study